NWORTH announce three new projects
We are delighted to announce that three new projects will be added to the NWORTH portfolio following recent grant funding success:
The Unit is beginning the set-up of The CALMED study, (The Clinical Effectiveness and Cost Effectiveness of Clozapine for inpatients with Borderline Personality Disorder: Randomised controlled trial), being led by Professor Mike Crawford, of Imperial College London. This study will investigate whether, among people receiving inpatient treatment for borderline personality disorder, the addition of clozapine to their usual care is a clinically effective and cost effective strategy for improving their mental health. This study will run from October 2018 – September 2021. This study is being funded by the NIHR HTA.
The team is starting work on another new study following the award of funding from NIHR PHR for the TOPIC study, (Improving the Oral Health of Older People in Care Homes: a Feasibility Study). This study is being led by Dr Georgios Tsakos from the Department of Epidemiology and Public Health at University College London. The study will run from December 2018 to May 2021 and will determine the feasibility of a multi-centre cluster-randomised controlled trial of a complex intervention based on a recent NICE guideline for the oral health of older people (those aged sixty-five years or older) in care homes.
We will be collaborating with Professor Richard Watt and his team from University College London on an NIHR PHR-funded award entitled: TOGETHER, A randomised controlled trial evaluating the effectiveness and cost effectiveness of “Strengthening Families, Strengthening Communities”: a community led parenting programme for families with children aged 3-18 years. This study will evaluate the Race Equality Foundation’s parenting program which was specifically designed to meet the needs of families from socially excluded & marginalised groups. The program will run across 7 English urban areas and be conducted in 2 phases from January 2019 – December 2022.
Publication date: 1 June 2018